Chinese herbal medicine-derived compounds for cancer therapy: A focus on hepatocellular carcinoma

Journal of Ethnopharmacology

Volumn 149, Issue 3, 2013, Pages 601-612

  Hu, Yangyang ^a   Wang, Shengpeng ^a   Wu, Xu ^b   Zhang, Jinming ^a   Chen, Ruie ^a   Chen, Meiwan ^a   Wang, Yitao ^a  

^a University of Macau   (Macao)

^b INSTITUTE OF CHINESE MATERIA MEDICA   (China)

Author keywords

Cancer therapy; Chinese herbal medicine; Curcumin; Hepatocellular carcinoma

Indexed keywords

ANTINEOPLASTIC AGENT; BERBERINE; CAVEOLIN 1; CELASTROL; CURCUMIN; CYCLIN D1; CYCLIN D3; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN E; CYCLINE; CYCLOOXYGENASE 2; CYTOCHROME C; FLUOROURACIL; GELATINASE B; HYPOXIA INDUCIBLE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOCHONDRIAL DNA; NATURAL PRODUCT; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN P53; QUERCETIN; RESVERATROL; SILIBININ; STAT3 PROTEIN; TANSHINONE IIA; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN;

ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CANCER INHIBITION; CANCER THERAPY; CELL ADHESION; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CHINESE MEDICINE; CHROMATIN CONDENSATION; DATA BASE; DNA BINDING; DNA DAMAGE; DRUG BIOAVAILABILITY; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; LIVER CELL CARCINOMA; MAXIMUM TOLERATED DOSE; MEDLINE; MITOCHONDRIAL MEMBRANE POTENTIAL; NONHUMAN; PATHOGENESIS; PHYTOCHEMISTRY; PROTEIN EXPRESSION; REVIEW;

SCOPUS;

ACTIVATOR PROTEIN 1; AKT; AP-1; ARNT; ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATE; ATP SYNTHASE H(+) TRANSPORTING MITOCHONDRIAL FO COMPLEX-SUBUNIT B1; ATP5F1; C-JUN N-TERMINAL KINASES; CANCER THERAPY; CAV1; CAVEOLIN-1; CDKS; CHINESE HERBAL MEDICINE; CHM; COX-2; CURCUMIN; CYCLIN DEPENDENT PROTEIN KINASES; CYCLOOXYGENASE-2; ELAM-1; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE; ERK1/2; EXTRACELLULAR REGULATED PROTEIN KINASES 1/2; HBV; HCC; HCV; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HEPATOCELLULAR CARCINOMA; HIF-1Α; HYPOXIA-INDUCIBLE FACTOR-ALPHA; ICAM-1; IL; INTERLEUKIN; INTRACELLULAR ADHESION MOLECULE; JNK; MAPK; MATRIX METALLOPROTEINASES; MITOGEN-ACTIVATED PROTEIN KINASES; MMP; PARP; PCNA; PHOSPHATASE AND TENSIN HOMOLOG; POLY ADP-RIBOSE POLYMERASE; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTEIN KINASE B; PTEN; REACTIVE OXYGEN SPECIES; ROS; SIGNAL TRANSDUCERS AND ACTIVATORS OF TRANSCRIPTION; STAT; TCM; TRADITIONAL CHINESE MEDICINE; UDP-GLUCURONOSYL TRANSFERASE; UGT; VASCULAR CELL ADHESION MOLECULE; VASCULAR ENDOTHELIAL GROWTH FACTOR.; VCAM-1; VEGF;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CARCINOMA, HEPATOCELLULAR; CHINA; DRUGS, CHINESE HERBAL; HUMANS; LIVER NEOPLASMS; MEDICINE, CHINESE TRADITIONAL;

EID: 84884414173     PISSN: 03788741     EISSN: 18727573     Source Type: Journal    
DOI: 10.1016/j.jep.2013.07.030     Document Type: Review

References (163)

1. N.M. Abdel-Hamid, M.H. Nazmy, A.W. Mahmoud, M.A. Fawzy, and M. Youssof A survey on herbal management of hepatocellular carcinoma World Journal of Hepatology 3 2011 175 183
2. B.B. Aggarwal, A. Kumar, and A.C. Bharti Anticancer potential of curcumin: preclinical and clinical studies Anticancer Research 23 2003 363 398
3. P. Anand, C. Sundaram, S. Jhurani, A.B. Kunnumakkara, and B.B. Aggarwal Curcumin and cancer: an "old-age" disease with an "age-old" solution Cancer Letters 267 2008 133 164
4. T. Asselah, and P. Marcellin Direct acting antivirals for the treatment of chronic hepatitis C: one pill a day for tomorrow Liver International 32 2012 88 102
5. M.K. Bae, S.H. Kim, J.W. Jeong, Y.M. Lee, H.S. Kim, S.R. Kim, I. Yun, S.K. Bae, and K.W. Kim Curcumin inhibits hypoxia-induced angiogenesis via down-regulation of HIF-1 Oncology Reports 15 2006 1557 1562
6. M. Bayet-Robert, F. Kwiatkowski, M. Leheurteur, F. Gachon, E. Planchat, C. Abrial, M.A. Mouret-Reynier, X. Durando, C. Barthomeuf, and P. Chollet Phase I dose escalation trial of docetaxel plus curcumin in patients with advanced and metastatic breast cancer Cancer Biology & Therapy 9 2010 8 14
7. A. Belot, P. Grosclaude, N. Bossard, E. Jougla, E. Benhamou, P. Delafosse, A.V. Guizard, F. Molinie, A. Danzon, S. Bara, A.M. Bouvier, B. Tretarre, F. Binder-Foucard, M. Colonna, L. Daubisse, G. Hedelin, G. Launoy, N. Le Stang, M. Maynadie, A. Monnereau, X. Troussard, J. Faivre, A. Collignon, I. Janoray, P. Arveux, A. Buemi, N. Raverdy, C. Schvartz, M. Bovet, L. Cherie-Challine, J. Esteve, L. Remontet, and M. Velten Cancer incidence and mortality in France over the period 1980-2005 Revue d'Epidemiologie et de Sante Publique 56 2008 159 175
8. A. Bishayee, and N. Dhir Resveratrol-mediated chemoprevention of diethylnitrosamine-initiated hepatocarcinogenesis: inhibition of cell proliferation and induction of apoptosis Chemico-biological Interactions 179 2009 131 144
9. J. Bode, U. Schmidt, and H. Dürr Silymarin for the treatment of acute viral hepatitis? Report of a controlled trial (author's transl) Medizinische Klinik 72 1977 513
10. P. Brafford, and M. Herlyn Gene expression profiling of melanoma cells - searching the haystack Journal of Translational Medicine 3 2005 2
11. V.A. Brown, K.R. Patel, M. Viskaduraki, J.A. Crowell, M. Perloff, T.D. Booth, G. Vasilinin, A. Sen, A.M. Schinas, G. Piccirilli, K. Brown, W.P. Steward, A.J. Gescher, and D.E. Brenner Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: safety, pharmacokinetics, and effect on the insulin-like growth factor axis Cancer Research 70 2010 9003 9011
12. C. Bunchorntavakul, and K. Reddy Review article: herbal and dietary supplement hepatotoxicity Alimentary Pharmacology & Therapeutics 37 2013 3 17
13. E.H. Cao, X.Q. Liu, J.J. Wang, and N.F. Xu Effect of natural antioxidant tanshinone II-A on DNA damage by lipid peroxidation in liver cells Free Radical Biology and Medicine 20 1996 801 806
14. J. Cao, L. Jia, H.M. Zhou, Y. Liu, and L.F. Zhong Mitochondrial and nuclear DNA damage induced by curcumin in human hepatoma G2 cells Toxicological Sciences 91 2006 476 483
15. J. Cao, Y. Liu, L. Jia, H.M. Zhou, Y. Kong, G. Yang, L.P. Jiang, Q.J. Li, and L.F. Zhong Curcumin induces apoptosis through mitochondrial hyperpolarization and mtDNA damage in human hepatoma G2 cells Free Radical Biology and Medicine 43 2007 968 975
16. S.L. Chan, and W. Yeo Targeted therapy of hepatocellular carcinoma: present and future Journal of Gastroenterology and Hepatology 27 2012 862 872
17. Y.F. Chang, C.W. Chi, and J.J. Wang Reactive oxygen species production is involved in quercetin-induced apoptosis in human hepatoma cells Nutrition and Cancer 55 2006 201 209
18. Y.F. Chang, Y.C. Hsu, H.F. Hung, H.J. Lee, W.Y. Lui, C.W. Chi, and J.J. Wang Quercetin induces oxidative stress and potentiates the apoptotic action of 2-methoxyestradiol in human hepatoma cells Nutrition and Cancer 61 2009 735 745
19. C. Chen, C. Chen, M. Wu, and T. Kuo Cancer potential in liver, lung, bladder and kidney due to ingested inorganic arsenic in drinking water British Journal of Cancer 66 1992 888 892
20. Z.m. Chen, B.q. Liu, J. Boreham, Y.p. Wu, J.s. Chen, and R. Peto Smoking and liver cancer in China: case-control comparison of 36,000 liver cancer deaths vs. 17,000 cirrhosis deaths International Journal of Cancer 107 2003 106 112
21. A.L. Cheng, C.H. Hsu, J.K. Lin, M.M. Hsu, Y.F. Ho, T.S. Shen, J.Y. Ko, J.T. Lin, B.R. Lin, W. Ming-Shiang, H.S. Yu, S.H. Jee, G.S. Chen, T.M. Chen, C.A. Chen, M.K. Lai, Y.S. Pu, M.H. Pan, Y.J. Wang, C.C. Tsai, and C.Y. Hsieh Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions Anticancer Research 21 2001 2895 2900
22. Y.S. Chi, H.G. Jong, K.H. Son, H.W. Chang, S.S. Kang, and H.P. Kim Effects of naturally occurring prenylated flavonoids on enzymes metabolizing arachidonic acid: cyclooxygenases and lipoxygenases Biochemical Pharmacology 62 2001 1185 1191
23. S.Y. Chien, S.J. Kuo, Y.L. Chen, D.R. Chen, C.Y. Cheng, and C.C. Su Tanshinone IIA inhibits human hepatocellular carcinoma J5 cell growth by increasing Bax and caspase 3 and decreasing CD31 expression in vivo Molecular Medicine Reports 5 2012 282 286
24. H. Choi, Y.S. Chun, S.W. Kim, M.S. Kim, and J.W. Park Curcumin inhibits hypoxia-inducible factor-1 by degrading aryl hydrocarbon receptor nuclear translocator: a mechanism of tumor growth inhibition Molecular Pharmacology 70 2006 1664 1671
25. S. Chuang, M. Kuo, C. Hsu, C. Chen, J. Lin, G. Lai, C. Hsieh, and A. Cheng Curcumin-containing diet inhibits diethylnitrosamine-induced murine hepatocarcinogenesis Carcinogenesis 21 2000 331 335
26. S.E. Chuang, A.L. Cheng, J.K. Lin, and M.L. Kuo Inhibition by curcumin of diethylnitrosamine-induced hepatic hyperplasia, inflammation, cellular gene products and cell-cycle-related proteins in rats Food and Chemical Toxicology 38 2000 991 995
27. R.H. Cichewicz, and S.A. Kouzi Resveratrol oligomers: structure, chemistry, and biological activity Studies in Natural Products Chemistry 26 2002 507 579
28. C.H. Cottart, V. Nivet-Antoine, C. Laguillier-Morizot, and J.L. Beaudeux Resveratrol bioavailability and toxicity in humans Molecular Nutrition & Food Research 54 2010 7 16
29. S.X. Cui, X.J. Qu, Y.Y. Xie, L. Zhou, M. Nakata, M. Makuuchi, and W. Tang Curcumin inhibits telomerase activity in human cancer cell lines International Journal of Molecular Medicine 18 2006 227 231
30. W. Cui, F. Gu, and K.Q. Hu Effects and mechanisms of silibinin on human hepatocellular carcinoma xenografts in nude mice World Journal of Gastroenterology 15 2009 1943 1950
31. Z.K. Dai, J.K. Qin, J.E. Huang, Y. Luo, Q. Xu, and H.L. Zhao Tanshinone IIA activates calcium-dependent apoptosis signaling pathway in human hepatoma cells Journal of Natural Medicines 66 2012 192 201
32. F. Dajas Life or death: neuroprotective and anticancer effects of quercetin Journal of Ethnopharmacology 143 2012 383 396
33. A.S. Darvesh, B.B. Aggarwal, and A. Bishayee Curcumin and liver cancer: a review Current Pharmaceutical Biotechnology 13 2012 218 228
34. D. Delmas, B. Jannin, M.M. Cherkaoui, and N. Latruffe Inhibitory effect of resveratrol on the proliferation of human and rat hepatic derived cell lines Oncology Reports 7 2000 847
35. H.B. El-Serag, J.A. Davila, N.J. Petersen, and K.A. McGlynn The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update Annals of Internal Medicine 139 2003 817
36. P.A. Farazi, and R.A. DePinho Hepatocellular carcinoma pathogenesis: from genes to environment Nature Reviews Cancer 6 2006 674 687
37. E.R. Fearon, and B. Vogelstein A genetic model for colorectal tumorigenesis Cell 61 1990 759 767
38. K. Flora, M. Hahn, H. Rosen, and K. Benner Milk thistle (Silybum marianum) for the therapy of liver disease The American Journal of Gastroenterology 93 1998 139 143
39. J. Gaspar, A. Rodrigues, A. Laires, F. Silva, S. Costa, M. Monteiro, C. Monteiro, and J. Rueff On the mechanisms of genotoxicity and metabolism of quercetin Mutagenesis 9 1994 445 449
40. A. Ghosh, D. Ghosh, S. Sarkar, A.K. Mandal, S. Thakur Choudhury, and N. Das Anticarcinogenic activity of nanoencapsulated quercetin in combating diethylnitrosamine-induced hepatocarcinoma in rats European Journal of Cancer Prevention 21 2012 32 41
41. D. Ghosh, S.T. Choudhury, S. Ghosh, A.K. Mandal, S. Sarkar, A. Ghosh, K.D. Saha, and N. Das Nanocapsulated curcumin: oral chemopreventive formulation against diethylnitrosamine induced hepatocellular carcinoma in rat Chemico-biological Interactions 195 2012 206 214
42. A.B. Granado-Serrano, M.A. Martin, L. Bravo, L. Goya, and S. Ramos Quercetin induces apoptosis via caspase activation, regulation of Bcl-2, and inhibition of PI-3-kinase/Akt and ERK pathways in a human hepatoma cell line (HepG2) The Journal of Nutrition 136 2006 2715 2721
43. F. Grizzi, and M. Chiriva-Internati Cancer: looking for simplicity and finding complexity Cancer Cell International 6 2006 4
44. Y.S. Guan, and Q. He Role of antiviral therapy in the management of hepatocellular carcinoma Anti-cancer Drugs 24 2013 337 343
45. D. Guo, C. Wu, J. Li, A. Guo, Q. Li, H. Jiang, B. Chen, and X. Wang Synergistic effect of functionalized nickel nanoparticles and quercetin on inhibition of the smmc-7721 cells proliferation Nanoscale Research Letters 4 2009 1395 1402
46. M.F. He, L. Liu, W. Ge, P.C. Shaw, R. Jiang, L.W. Wu, and P. But Antiangiogenic activity of Tripterygium wilfordii and its terpenoids Journal of Ethnopharmacology 121 2009 61
47. Q. Hou, X. Tang, H. Liu, J. Tang, Y. Yang, X. Jing, Q. Xiao, W. Wang, X. Gou, and Z. Wang Berberine induces cell death in human hepatoma cells in vitro by downregulating CD147 Cancer Science 102 2011 1287 1292
48. J.M. Hur, M.S. Hyun, S.Y. Lim, W.Y. Lee, and D. Kim The combination of berberine and irradiation enhances anti-cancer effects via activation of p38 MAPK pathway and ROS generation in human hepatoma cells Journal of Cellular Biochemistry 107 2009 955 964
49. J.M. Hwang, H.C. Kuo, T.H. Tseng, J.Y. Liu, and C.Y. Chu Berberine induces apoptosis through a mitochondria/caspases pathway in human hepatoma cells Archives of Toxicology 80 2006 62 73
50. E. Ierardi, R. Rosania, M. Zotti, F. Giorgio, S. Prencipe, N.D. Valle, V.D. Francesco, and C. Panella From chronic liver disorders to hepatocellular carcinoma: molecular and genetic pathways World Journal of Gastrointestinal Oncology 2 2010 259 264
51. A. Jemal, F. Bray, M.M. Center, J. Ferlay, E. Ward, and D. Forman Global cancer statistics CA: A Cancer Journal for Clinicians 61 2011 69 90
52. M.C. Jiang, H.F. Yang-Yen, J.K. Lin, and J.J. Yen Differential regulation of p53, c-Myc, Bcl-2 and Bax protein expression during apoptosis induced by widely divergent stimuli in human hepatoblastoma cells Oncogene 13 1996 609 616
53. S. Jie, H. Li, Y. Tian, D. Guo, J. Zhu, S. Gao, and L. Jiang Berberine inhibits angiogenic potential of Hep G2 cell line through VEGF down-regulation in vitro Journal of Gastroenterology and Hepatology 26 2011 179 185
54. H.W. Jung, Y.S. Chung, Y.S. Kim, and Y.K. Park Celastrol inhibits production of nitric oxide and proinflammatory cytokines through MAPK signal transduction and NF-kappaB in LPS-stimulated BV-2 microglial cells Experimental & Molecular Medicine 39 2007 715 721
55. R. Kannaiyan, K.A. Manu, L. Chen, F. Li, P. Rajendran, A. Subramaniam, P. Lam, A.P. Kumar, and G. Sethi Celastrol inhibits tumor cell proliferation and promotes apoptosis through the activation of c-Jun N-terminal kinase and suppression of PI3 K/Akt signaling pathways Apoptosis 16 2011 1028 1041
56. K.A. Khaled, Y.M. El-Sayed, and B.M. Al-Hadiya Disposition of the flavonoid quercetin in rats after single intravenous and oral doses Drug Development and Industrial Pharmacy 29 2003 397 403
57. A.D. Kinghorn, B.N. Su, D.S. Jang, L.C. Chang, D. Lee, J.Q. Gu, E.J. Carcache-Blanco, A.D. Pawlus, S.K. Lee, and E.J. Park Natural inhibitors of carcinogenesis Planta Medica 70 2004 691 705
58. Y.H. Kuang, X. Chen, J. Su, L.S. Wu, L.Q. Liao, D. Li, Z.S. Chen, and T. Kanekura RNA interference targeting the CD147 induces apoptosis of multi-drug resistant cancer cells related to XIAP depletion Cancer Letters 276 2009 189 195
59. A.B. Kunnumakkara, P. Anand, and B.B. Aggarwal Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins Cancer Letters 269 2008 199 225
60. C.L. Kuo, C.W. Chi, and T.Y. Liu The anti-inflammatory potential of berberine in vitro and in vivo Cancer Letters 203 2004 127 137
61. P.L. Kuo, L.C. Chiang, and C.C. Lin Resveratrol-induced apoptosis is mediated by p53-dependent pathway in Hep G2 cells Life Sciences 72 2002 23 34
62. M. Labbozzetta, M. Notarbartolo, P. Poma, L. Giannitrapani, M. Cervello, G. Montalto, and N. D'Alessandro Significance of autologous interleukin-6 production in the HA22T/VGH cell model of hepatocellular carcinoma Annals of the New York, Academy of Sciences 1089 2006 268 275
63. J.J. Lah, W. Cui, and K.Q. Hu Effects and mechanisms of silibinin on human hepatoma cell lines World Journal of Gastroenterology 13 2007 5299 5305
64. E.C. Lai, and W.Y. Lau The continuing challenge of hepatic cancer in Asia Surgeon 3 2005 210 215
65. A. Lancon, N. Hanet, B. Jannin, D. Delmas, J.M. Heydel, G. Lizard, M.C. Chagnon, Y. Artur, and N. Latruffe Resveratrol in human hepatoma HepG2 cells: metabolism and inducibility of detoxifying enzymes Drug Metabolism and Disposition 35 2007 699 703
66. C.F. Lee, Z.Q. Ling, T. Zhao, and K.R. Lee Distinct expression patterns in hepatitis B virus- and hepatitis C virus-infected hepatocellular carcinoma World Journal of Gastroenterology 14 2008 6072 6077
67. E.O. Lee, H.J. Lee, H.S. Hwang, K.S. Ahn, C. Chae, K.S. Kang, J. Lu, and S.H. Kim Potent inhibition of Lewis lung cancer growth by heyneanol A from the roots of Vitis amurensis through apoptotic and anti-angiogenic activities Carcinogenesis 27 2006 2059 2069
68. M. Li-Weber Targeting apoptosis pathways in cancer by Chinese medicine Cancer Letters 332 2010 304 312
69. L. Li, J. Zeng, Y. Gao, and D. He Targeting silibinin in the antiproliferative pathway Expert Opinion on Investigational Drugs 19 2010 243 255
70. Q. Li, Y. Wang, N. Feng, Z. Fan, J. Sun, and Y. Nan Novel polymeric nanoparticles containing tanshinone IIA for the treatment of hepatoma Journal of Drug Targeting 16 2008 725 732
71. Y. Li, and R.C. Martin Herbal medicine and hepatocellular carcinoma: applications and challenges Evidence-based Complementary and Alternative Medicine 2011 2011 541209
72. H.C. Lin, Y.F. Chen, W.H. Hsu, C.W. Yang, C.H. Kao, and T.F. Tsai Resveratrol helps recovery from fatty liver and protects against hepatocellular carcinoma induced by hepatitis B virus X protein in a mouse model Cancer Prevention Research 5 2012 952 962
73. L.I. Lin, Y.F. Ke, Y.C. Ko, and J.K. Lin Curcumin inhibits SK-Hep-1 hepatocellular carcinoma cell invasion in vitro and suppresses matrix metalloproteinase-9 secretion Oncology 55 1998 349 353
74. B. Liu, G. Wang, J. Yang, X. Pan, Z. Yang, and L. Zang Berberine inhibits human hepatoma cell invasion without cytotoxicity in healthy hepatocytes PLoS One 6 2011 e21416
75. M. Lopez-Lazaro Anticancer and carcinogenic properties of curcumin: considerations for its clinical development as a cancer chemopreventive and chemotherapeutic agent Molecular Nutrition & Food Research 52 2008 S103 S127
76. S.C. Lu Where are we in the chemoprevention of hepatocellular carcinoma? Hepatology 51 2010 734 736
77. J.M. Luk, X. Wang, P. Liu, K.F. Wong, K.L. Chan, Y. Tong, C.K. Hui, G.K. Lau, and S.T. Fan Traditional Chinese herbal medicines for treatment of liver fibrosis and cancer: from laboratory discovery to clinical evaluation Liver International 27 2007 879 890
78. Z. Meng, P. Yang, Y. Shen, W. Bei, Y. Zhang, Y. Ge, R.A. Newman, L. Cohen, L. Liu, and B. Thornton Pilot study of huachansu in patients with hepatocellular carcinoma, nonsmall-cell lung cancer, or pancreatic cancer Cancer 115 2009 5309 5318
79. D. Metodiewa, A.K. Jaiswal, N. Cenas, E. Dickancaité, and J. Segura-Aguilar Quercetin may act as a cytotoxic prooxidant after its metabolic activation to semiquinone and quinoidal product Free Radical Biology and Medicine 26 1999 107 116
80. G. Michels, W. Watjen, N. Weber, P. Niering, Y. Chovolou, A. Kampkotter, P. Proksch, and R. Kahl Resveratrol induces apoptotic cell death in rat H4IIE hepatoma cells but necrosis in C6 glioma cells Toxicology 225 2006 173 182
81. F. Michor, Y. Iwasa, C. Lengauer, and M.A. Nowak Dynamics of colorectal cancer Seminars in Cancer Biology 15 2005 484 493
82. M. Momeny, M.R. Khorramizadeh, S.H. Ghaffari, M. Yousefi, M.S. Yekaninejad, R. Esmaeili, Z. Jahanshiri, and M.R. Nooridaloii Effects of silibinin on cell growth and invasive properties of a human hepatocellular carcinoma cell line, HepG-2, through inhibition of extracellular signal-regulated kinase 1/2 phosphorylation European Journal of Pharmacology 591 2008 13 20
83. A. Murakami, H. Ashida, and J. Terao Multitargeted cancer prevention by quercetin Cancer Letters 269 2008 315 325
84. T. Nguyen, E. Tran, T. Nguyen, P. Do, T. Huynh, and H. Huynh The role of activated MEK-ERK pathway in quercetin-induced growth inhibition and apoptosis in A549 lung cancer cells Carcinogenesis 25 2004 647 659
85. L. Ning, L. Wentworth, H. Chen, and S.M. Weber Down-regulation of Notch1 signaling inhibits tumor growth in human hepatocellular carcinoma American Journal of Translational Research 1 2009 358 366
86. N. Nishida, and A. Goel Genetic and epigenetic signatures in human hepatocellular carcinoma: a systematic review Current Genomics 12 2011 130 137
87. N. Nishida, and M. Kudo Recent advancements in comprehensive genetic analyses for human hepatocellular carcinoma Oncology 84 2013 93 97
88. M. Notarbartolo, P. Poma, D. Perri, L. Dusonchet, M. Cervello, and N. D'Alessandro Antitumor effects of curcumin, alone or in combination with cisplatin or doxorubicin, on human hepatic cancer cells. Analysis of their possible relationship to changes in NF-kB activation levels and in IAP gene expression Cancer Letters 224 2005 53 65
89. G. Notas, A.P. Nifli, M. Kampa, J. Vercauteren, E. Kouroumalis, and E. Castanas Resveratrol exerts its antiproliferative effect on HepG2 hepatocellular carcinoma cells, by inducing cell cycle arrest, and NOS activation Biochimica et Biophysica Acta 1760 2006 1657 1666
90. Y. Ohashi, Y. Tsuchiya, K. Koizumi, H. Sakurai, and I. Saiki Prevention of intrahepatic metastasis by curcumin in an orthotopic implantation model Oncology 65 2003 250 258
91. Y. Ohene-Abuakwa, and M. Pignatelli Adhesion molecules as diagnostic tools in tumor pathology International Journal of Surgical Pathology 8 2000 191 200
92. K.T. Padhya, J.A. Marrero, and A.G. Singal Recent advances in the treatment of hepatocellular carcinoma Current Opinion in Gastroenterology 29 2013 285 292
93. H. Pan, X. Fu, and W. Huang Molecular mechanism of liver cancer Anti-cancer Agents in Medicinal Chemistry 11 2011 493 499
94. M.H. Pan, T.M. Huang, and J.K. Lin Biotransformation of curcumin through reduction and glucuronidation in mice Drug Metabolism and Disposition 27 1999 486 494
95. P. Parekh, L. Motiwale, N. Naik, and K. Rao Downregulation of cyclin D1 is associated with decreased levels of p38 MAP kinases, Akt/PKB and Pak1 during chemopreventive effects of resveratrol in liver cancer cells Experimental and Toxicologic Pathology 63 2011 167 173
96. P. Parekh, and K. Rao Overexpression of cyclin D1 is associated with elevated levels of MAP kinases, Akt and Pak1 during diethylnitrosamine-induced progressive liver carcinogenesis Cell Biology International 31 2007 35 43
97. K.R. Patel, E. Scott, V.A. Brown, A.J. Gescher, W.P. Steward, and K. Brown Clinical trials of resveratrol Annals of the New York Academy of Sciences 1215 2013 161 169
98. J.F. Perz, G.L. Armstrong, L.A. Farrington, Y.J. Hutin, and B.P. Bell The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide Journal of Hepatology 45 2006 529 538
99. S. Priya, and P.R. Sudhakaran Cell survival, activation and apoptosis of hepatic stellate cells: modulation by extracellular matrix proteins Hepatology Research 38 2008 1221 1232
100. S. Rajamanickam, B. Velmurugan, M. Kaur, R.P. Singh, and R. Agarwal Chemoprevention of intestinal tumorigenesis in APCmin/+ mice by silibinin Cancer Research 70 2010 2368 2378
101. P. Rajendran, F. Li, M.K. Shanmugam, R. Kannaiyan, J.N. Goh, K.F. Wong, W. Wang, E. Khin, V. Tergaonkar, A.P. Kumar, J.M. Luk, and G. Sethi Celastrol suppresses growth and induces apoptosis of human hepatocellular carcinoma through the modulation of STAT3/JAK2 signaling cascade in vitro and in vivo Cancer Prevention Research 5 2012 631 643
102. G. Ramakrishnan, L. Lo Muzio, C. Elinos-Báez, S. Jagan, T. Augustine, S. Kamaraj, P. Anandakumar, and T. Devaki Silymarin inhibited proliferation and induced apoptosis in hepatic cancer cells Cell Proliferation 42 2009 229 240
103. L. Roncoroni, L. Elli, E. Dolfini, E. Erba, E. Dogliotti, C. Terrani, L. Doneda, M.G. Grimoldi, and M.T. Bardella Resveratrol inhibits cell growth in a human cholangiocarcinoma cell line Liver International 28 2008 1426 1436
104. M. Russo, C. Spagnuolo, I. Tedesco, S. Bilotto, and G.L. Russo The flavonoid quercetin in disease prevention and therapy: facts and fancies Biochemical Pharmacology 83 2012 6 15
105. R. Saller, R. Meier, and R. Brignoli The use of silymarin in the treatment of liver diseases Drugs 61 2001 2035 2063
106. A. Sangiovanni, E. Del Ninno, P. Fasani, C. De Fazio, G. Ronchi, R. Romeo, A. Morabito, R. De Franchis, and M. Colombo Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance Gastroenterology 126 2004 1005 1014
107. M.K. Shanmugam, A.H. Nguyen, A.P. Kumar, B.K. Tan, and G. Sethi Targeted inhibition of tumor proliferation, survival, and metastasis by pentacyclic triterpenoids: potential role in prevention and therapy of cancer Cancer Letters 320 2012 158 170
108. R.A. Sharma, S.A. Euden, S.L. Platton, D.N. Cooke, A. Shafayat, H.R. Hewitt, T.H. Marczylo, B. Morgan, D. Hemingway, S.M. Plummer, M. Pirmohamed, A.J. Gescher, and W.P. Steward Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance Clinical Cancer Research 10 2004 6847 6854
109. S.C. Shen, Y.C. Chen, F.L. Hsu, and W.R. Lee Differential apoptosis-inducing effect of quercetin and its glycosides in human promyeloleukemic HL-60 cells by alternative activation of the caspase 3 cascade Journal of Cellular Biochemistry 89 2003 1044 1055
110. A.B. Siegel, R. Narayan, R. Rodriguez, A. Goyal, J.S. Jacobson, K. Kelly, E. Ladas, P.J. Lunghofer, R.J. Hansen, D.L. Gustafson, T.W. Flaig, W.Y. Tsai, D.P. Wu, V. Lee, and H. Greenlee A phase I dose-finding study of silybin phosphatidylcholine (milk thistle) in patients with advanced hepatocellular carcinoma Integrative Cancer Therapies 2013 (In press)
111. R.P. Singh, S. Dhanalakshmi, C. Agarwal, and R. Agarwal Silibinin strongly inhibits growth and survival of human endothelial cells via cell cycle arrest and downregulation of survivin, Akt and NF-κB: implications for angioprevention and antiangiogenic therapy Oncogene 24 2004 1188 1202
112. R.P. Singh, K. Raina, G. Deep, D. Chan, and R. Agarwal Silibinin suppresses growth of human prostate carcinoma PC-3 orthotopic xenograft via activation of extracellular signal-regulated kinase 1/2 and inhibition of signal transducers and activators of transcription signaling Clinical Cancer Research 15 2009 613 621
113. R.L. Singhal, Y.A. Yeh, N. Prajda, E. Olah, G. Sledge, and G. Weber Quercetin down-regulates signal transduction in human breast carcinoma cells Biochemical and Biophysical Research Communications 208 1995 425 431
114. M.W. Smith, Z.N. Yue, G.K. Geiss, N.Y. Sadovnikova, V.S. Carter, L. Boix, C.A. Lazaro, G.B. Rosenberg, R.E. Bumgarner, N. Fausto, J. Bruix, and M.G. Katze Identification of novel tumor markers in hepatitis C virus-associated hepatocellular carcinoma Cancer Research 63 2003 859 864
115. D.B. Strader, B.R. Bacon, K.L. Lindsay, D.R. La Brecque, T. Morgan, E.C. Wright, J. Allen, M.F. Khokar, J.H. Hoofnagle, and L.B. Seeff Use of complementary and alternative medicine in patients with liver disease The American Journal of Gastroenterology 97 2002 2391 2397
116. L. Subramanian, S. Youssef, S. Bhattacharya, J. Kenealey, A.S. Polans, and P.R. van Ginkel Resveratrol: challenges in translation to the clinic - a critical discussion Clinical Cancer Research 16 2010 5942 5948
117. Z.J. Sun, C.E. Pan, H.S. Liu, and G.J. Wang Anti-hepatoma activity of resveratrol in vitro World Journal of Gastroenterology 8 2002 79 81
118. W. Tan, Y. Li, M. Chen, and Y. Wang Berberine hydrochloride: anticancer activity and nanoparticulate delivery system International Journal of Nanomedicine 6 2011 1773 1777
119. W. Tan, J. Lu, M. Huang, Y. Li, M. Chen, G. Wu, J. Gong, Z. Zhong, Z. Xu, Y. Dang, J. Guo, X. Chen, and Y. Wang Anti-cancer natural products isolated from Chinese medicinal herbs Chinese Medicine 6 2011 27
120. J. Tang, Y. Feng, S. Tsao, N. Wang, R. Curtain, and Y. Wang Berberine and Coptidis rhizoma as novel antineoplastic agents: a review of traditional use and biomedical investigations Journal of Ethnopharmacology 126 2009 5 17
121. J. Tang, Y.M. Wu, P. Zhao, X.M. Yang, J.L. Jiang, and Z.N. Chen Overexpression of HAb18G/CD147 promotes invasion and metastasis via α3β1 integrin mediated FAK-paxillin and FAK-PI3K-Ca 2+ pathways Cellular and Molecular Life Sciences 65 2008 2933 2942
122. Y. Tang, M.T. Nakada, P. Kesavan, F. McCabe, H. Millar, P. Rafferty, P. Bugelski, and L. Yan Extracellular matrix metalloproteinase inducer stimulates tumor angiogenesis by elevating vascular endothelial cell growth factor and matrix metalloproteinases Cancer Research 65 2005 3193 3199
123. S. Tanigawa, M. Fujii, and D.X. Hou Stabilization of p53 is involved in quercetin-induced cell cycle arrest and apoptosis in HepG2 cells Bioscience, Biotechnology, and Biochemistry 72 2008 797 804
124. H.H. Thein, S.R. Walter, H.F. Gidding, J. Amin, M.G. Law, J. George, and G.J. Dore Trends in incidence of hepatocellular carcinoma after diagnosis of hepatitis B or C infection: a population-based cohort study, 1992-2007 Journal of Viral Hepatitis 18 2011 e232 e241
125. S.S. Thorgeirsson, and J.W. Grisham Molecular pathogenesis of human hepatocellular carcinoma Nature Genetics 31 2002 339 346
126. M. Tillhon, L.M. Guaman Ortiz, P. Lombardi, and A.I. Scovassi Berberine: new perspectives for old remedies Biochemical Pharmacology 84 2012 1260 1267
127. I. Tolmane, B. Rozentale, J. Keiss, F. Arsa, G. Brigis, and A. Zvaigzne The prevalence of viral hepatitis C in Latvia: a population-based study Medicina (Kaunas) 47 2011 532 535
128. A.J. Vargas, and R. Burd Hormesis and synergy: pathways and mechanisms of quercetin in cancer prevention and management Nutrition Reviews 68 2010 418 428
129. L. Varghese, C. Agarwal, A. Tyagi, R.P. Singh, and R. Agarwal Silibinin efficacy against human hepatocellular carcinoma Clinical Cancer Research 11 2005 8441 8448
130. V.R. Vasquez-Garzon, J.R. Macias-Perez, M.N. Jimenez-Garcia, V. Villegas, S. Fattel-Fazenta, and S. Villa-Trevino The chemopreventive capacity of quercetin to induce programmed cell death in hepatocarcinogenesis Toxicologic Pathology 2012 1 9 (00)
131. G. Wang, J. Zhang, L. Liu, S. Sharma, and Q. Dong Quercetin potentiates doxorubicin mediated antitumor effects against liver cancer through p53/Bcl-xl PLoS One 7 2012 e51764
132. N. Wang, Y. Feng, E.P.W. Lau, C. Tsang, Y. Ching, K. Man, Y. Tong, T. Nagamatsu, W. Su, and S. Tsao F-actin reorganization and inactivation of rho signaling pathway involved in the inhibitory effect of Coptidis rhizoma on hepatoma cell migration Integrative Cancer Therapies 9 2010 354 364
133. N. Wang, Y. Feng, M. Zhu, C.M. Tsang, K. Man, Y. Tong, and S.W. Tsao Berberine induces autophagic cell death and mitochondrial apoptosis in liver cancer cells: the cellular mechanism Journal of Cellular Biochemistry 111 2010 1426 1436
134. S. Wang, Y. Hu, W. Tan, X. Wu, R. Chen, J. Cao, M. Chen, and Y. Wang Compatibility art of traditional Chinese medicine: from the perspective of herb pairs Journal of Ethnopharmacology 143 2012 412 423
135. S. Wang, K. Liu, X. Wang, Q. He, and X. Chen Toxic effects of celastrol on embryonic development of zebrafish (Danio rerio) Drug and Chemical Toxicology 34 2012 61 65
136. S. Wang, X. Wu, M. Tan, J. Gong, W. Tan, B. Bian, M. Chen, and Y. Wang Fighting fire with fire: poisonous Chinese herbal medicine for cancer therapy Journal of Ethnopharmacology 140 2012 33 45
137. S.P. Wang, M. Tan, Z.F. Zhong, M.W. Chen, and Y.T. Wang Nanotechnologies for curcumin: an ancient puzzler meets modern solutions Journal of Nanomaterials 2011 2011 1 8
138. W.Q. Wang, L. Liu, H.C. Sun, Y.L. Fu, H.X. Xu, Z.T. Chai, Q.B. Zhang, L.Q. Kong, X.D. Zhu, L. Lu, Z.G. Ren, and Z.Y. Tang Tanshinone IIA inhibits metastasis after palliative resection of hepatocellular carcinoma and prolongs survival in part via vascular normalization Journal of Hematology & Oncology 5 2012 69
139. W.Z. Wang, J. Cheng, J. Luo, and S.M. Zhuang Abrogation of G2/M arrest sensitizes curcumin-resistant hepatoma cells to apoptosis FEBS Letters 582 2008 2689 2695
140. X.N. Wang, X. Han, L.N. Xu, L.H. Yin, Y.W. Xu, Y. Qi, and J.Y. Peng Enhancement of apoptosis of human hepatocellular carcinoma SMMC-7721 cells through synergy of berberine and evodiamine Phytomedicine 15 2008 1062 1068
141. S. Whittaker, R. Marais, and A.X. Zhu The role of signaling pathways in the development and treatment of hepatocellular carcinoma Oncogene 29 2010 4989 5005
142. WHO, 2002. Department of Communicable Diseases Surveillance and Response. Hepatitis B. Available at: http://www.who.int/csr/disease/hepatitis/HepatitisB- whocdscsrlyo2002-2.pdf.
143. G.N. Wogan Aflatoxins as risk factors for hepatocellular carcinoma in humans Cancer Research 52 1992 2114s 2118s
144. J.S. Woo, T.S. Kim, J.H. Park, and S.C. Chi Formulation and biopharmaceutical evaluation of silymarin using SMEDDS Archives of Pharmacal Research 30 2007 82 89
145. W.L. Wu, W.L. Chang, and C.F. Chen Cytotoxic activities of tanshinones against human carcinoma cell lines The American Journal of Chinese Medicine 19 1991 207 216
146. J. Xiao, Y. Chu, K. Hu, J. Wan, Y. Huang, C. Jiang, G. Liang, and X. Li Synthesis and biological analysis of a new curcumin analogue for enhanced anti-tumor activity in HepG 2 cells Oncology Reports 23 2010 1435 1441
147. J. Xu, L. Wang, and B. Xu Research development of Coptis chinensis Acta Academiae Medicinae Sinicae 26 2004 704 707
148. J. Xu, H.Y. Xu, Q. Zhang, F. Song, J.L. Jiang, X.M. Yang, L. Mi, N. Wen, R. Tian, and L. Wang HAb18G/CD147 functions in invasion and metastasis of hepatocellular carcinoma Molecular Cancer Research 5 2007 605 614
149. H. Yang, W. Chen, X. Cao, A. Worschech, L. Du, W. Fang, Y. Xu, D.F. Stroncek, X. Li, and E. Wang Caveolin-1 enhances resveratrol-mediated cytotoxicity and transport in a hepatocellular carcinoma model Journal of Translational Medicine 7 2009 22
150. J.M. Yang, P. O'Neill, W. Jin, R. Foty, D.J. Medina, Z. Xu, M. Lomas, G.M. Arndt, Y. Tang, and M. Nakada Extracellular matrix metalloproteinase inducer (CD147) confers resistance of breast cancer cells to Anoikis through inhibition of Bim Journal of Biological Chemistry 281 2006 9719 9727
151. K.Y. Yang, L.C. Lin, T.Y. Tseng, S.C. Wang, and T.H. Tsai Oral bioavailability of curcumin in rat and the herbal analysis from Curcuma longa by LC-MS/MS Journal of Chromatography B 853 2007 183 189
152. C.B. Yeh, M.J. Hsieh, C.W. Lin, H.L. Chiou, P.Y. Lin, T.Y. Chen, and S.F. Yang The antimetastatic effects of resveratrol on hepatocellular carcinoma through the downregulation of a metastasis-associated protease by SP-1 modulation PLoS One 8 2013 e56661
153. P. Yoysungnoen, P. Wirachwong, P. Bhattarakosol, H. Niimi, and S. Patumraj Antiangiogenic activity of curcumin in hepatocellular carcinoma cells implanted nude mice Clinical Hemorheology and Microcirculation 33 2005 127 135
154. P. Yoysungnoen, P. Wirachwong, P. Bhattarakosol, H. Niimi, and S. Patumraj Effects of curcumin on tumor angiogenesis and biomarkers, COX-2 and VEGF, in hepatocellular carcinoma cell-implanted nude mice Clinical Hemorheology and Microcirculation 34 2006 109 115
155. P. Yoysungnoen, P. Wirachwong, C. Changtam, A. Suksamrarn, and S. Patumraj Anti-cancer and anti-angiogenic effects of curcumin and tetrahydrocurcumin on implanted hepatocellular carcinoma in nude mice World Journal of Gastroenterology 14 2008 2003 2009
156. H.B. Yu, H.F. Zhang, X. Zhang, D.Y. Li, H.Z. Xue, C.E. Pan, and S.H. Zhao Resveratrol inhibits VEGF expression of human hepatocellular carcinoma cells through a NF-kappa B-mediated mechanism Hepatogastroenterology 57 2010 1241 1246
157. J.M. Yuan, S. Govindarajan, K. Arakawa, and M.C. Yu Synergism of alcohol, diabetes, and viral hepatitis on the risk of hepatocellular carcinoma in blacks and whites in the US Cancer 101 2004 1009 1017
158. S.L. Yuan, Y.Q. Wei, X.J. Wang, F. Xiao, S.F. Li, and J. Zhang Growth inhibition and apoptosis induction of tanshinone II-A on human hepatocellular carcinoma cells World Journal of Gastroenterology 10 2004 2024 2028
159. X. Yuxian, T. Feng, L. Ren, and L. Zhengcai Tanshinone II-A inhibits invasion and metastasis of human hepatocellular carcinoma cells in vitro and in vivo Tumori 95 2009 789 795
160. D. Zhang, L. Xu, F. Cao, T. Wei, C. Yang, G. Uzan, and B. Peng Celastrol regulates multiple nuclear transcription factors belonging to HSP90's clients in a dose-and cell type-dependent way Cell Stress and Chaperones 15 2010 939 946
161. Q. Zhang, X. Tang, Q.Y. Lu, Z.F. Zhang, J. Brown, and A.D. Le Resveratrol inhibits hypoxia-induced accumulation of hypoxia-inducible factor-1α and VEGF expression in human tongue squamous cell carcinoma and hepatoma cells Molecular Cancer Therapeutics 4 2005 1465 1474
162. B.L. Zhao, W. Jiang, Y. Zhao, J.W. Hou, and W.J. Xin Scavenging effects of salvia miltiorrhiza on free radicals and its protection for myocardial mitochondrial membranes from ischemia-reperfusion injury Biochemistry and Molecular Biology International 38 1996 1171
163. J. Zhao, and R. Agarwal Tissue distribution of silibinin, the major active constituent of silymarin, in mice and its association with enhancement of phase II enzymes: implications in cancer chemoprevention Carcinogenesis 20 1999 2101 2108